Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular matrix protein X-linked, pseudogene (ECMXP) is a genomic locus classified as a pseudogene—that is, a genomic DNA sequence similar to a known protein-coding gene but presumed to be nonfunctional due to mutation or truncation. Pseudogenes such as ECMXP do not typically encode active proteins and are not conventional drug targets, but recent evidence suggests that some pseudogenes may regulate gene function through the production of non-coding RNA transcripts. These transcripts can affect biological processes by acting as molecular decoys for microRNAs or RNA-binding proteins or by generating regulatory RNAs. However, there is no specific evidence or published literature indicating a biological or disease role for ECMXP itself[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix protein X-linked, pseudogene (ECMXP).